- Home
- ICMB vs ATRA Comparison
ICMB vs ATRA Comparison
Compare ICMB & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- ATRA
- Stock Information
- Founded
- ICMB 2012
- ATRA 2012
- Country
- ICMB United States
- ATRA United States
- Employees
- ICMB N/A
- ATRA N/A
- Industry
- ICMB Finance: Consumer Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ICMB Finance
- ATRA Health Care
- Exchange
- ICMB Nasdaq
- ATRA Nasdaq
- Market Cap
- ICMB 41.1M
- ATRA 40.1M
- IPO Year
- ICMB N/A
- ATRA 2014
- Fundamental
- Price
- ICMB $2.75
- ATRA $7.80
- Analyst Decision
- ICMB
- ATRA Buy
- Analyst Count
- ICMB 0
- ATRA 5
- Target Price
- ICMB N/A
- ATRA $17.75
- AVG Volume (30 Days)
- ICMB 27.4K
- ATRA 44.9K
- Earning Date
- ICMB 05-13-2025
- ATRA 08-11-2025
- Dividend Yield
- ICMB 17.27%
- ATRA N/A
- EPS Growth
- ICMB N/A
- ATRA N/A
- EPS
- ICMB 0.82
- ATRA N/A
- Revenue
- ICMB $20,996,189.00
- ATRA $199,732,000.00
- Revenue This Year
- ICMB N/A
- ATRA N/A
- Revenue Next Year
- ICMB N/A
- ATRA N/A
- P/E Ratio
- ICMB $3.37
- ATRA N/A
- Revenue Growth
- ICMB N/A
- ATRA 475.53
- 52 Week Low
- ICMB $2.46
- ATRA $5.01
- 52 Week High
- ICMB $3.47
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- ICMB 45.17
- ATRA 46.56
- Support Level
- ICMB $2.75
- ATRA $7.51
- Resistance Level
- ICMB $2.95
- ATRA $8.25
- Average True Range (ATR)
- ICMB 0.11
- ATRA 0.47
- MACD
- ICMB -0.00
- ATRA -0.12
- Stochastic Oscillator
- ICMB 18.00
- ATRA 17.11
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).